BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 31556691)

  • 1. Pyrrolo[2,1-
    Matveeva MD; Purgatorio R; Voskressensky LG; Altomare CD
    Future Med Chem; 2019 Oct; 11(20):2735-2755. PubMed ID: 31556691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Class of 1-Aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline Derivatives as Reversers of P-Glycoprotein-Mediated Multidrug Resistance in Tumor Cells.
    Nevskaya AA; Matveeva MD; Borisova TN; Niso M; Colabufo NA; Boccarelli A; Purgatorio R; de Candia M; Cellamare S; Voskressensky LG; Altomare CD
    ChemMedChem; 2018 Aug; 13(15):1588-1596. PubMed ID: 29802687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Application of Pyrrolo[2, 3-d]pyrimidine Scaffold in Medicinal Chemistry from 2017 to 2021.
    Liang T; Yang Y; Wang J; Xie Z; Chen X
    Mini Rev Med Chem; 2023; 23(10):1118-1136. PubMed ID: 36635929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5,6-Dihydropyrrolo[2,1-a]isoquinolines as Alternative of New Drugs with Cytotoxic Activity.
    Chávez-Santos RM; Reyes-Gutiérrez PE; Torres-Ochoa RO; Ramírez-Apan MT; Martínez R
    Chem Pharm Bull (Tokyo); 2017 Oct; 65(10):973-981. PubMed ID: 28740026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer and Reversing Multidrug Resistance Activities of Natural Isoquinoline Alkaloids and their Structure-activity Relationship.
    Qing ZX; Huang JL; Yang XY; Liu JH; Cao HL; Xiang F; Cheng P; Zeng JG
    Curr Med Chem; 2018; 25(38):5088-5114. PubMed ID: 28933285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive pyrrole-based compounds with target selectivity.
    Li Petri G; Spanò V; Spatola R; Holl R; Raimondi MV; Barraja P; Montalbano A
    Eur J Med Chem; 2020 Dec; 208():112783. PubMed ID: 32916311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Cytotoxic and Antiviral Profiling of Pyrrolo- and Furo-Fused 7-Deazapurine Ribonucleosides.
    Tokarenko A; Lišková B; Smoleń S; Táborská N; Tichý M; Gurská S; Perlíková P; Frydrych I; Tloušt'ová E; Znojek P; Mertlíková-Kaiserová H; Poštová Slavětínská L; Pohl R; Klepetářová B; Khalid NU; Wenren Y; Laposa RR; Džubák P; Hajdúch M; Hocek M
    J Med Chem; 2018 Oct; 61(20):9347-9359. PubMed ID: 30281308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naturally occurring plant isoquinoline N-oxide alkaloids: their pharmacological and SAR activities.
    Dembitsky VM; Gloriozova TA; Poroikov VV
    Phytomedicine; 2015 Jan; 22(1):183-202. PubMed ID: 25636889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 5,6-dihydropyrrolo[2,1-a]isoquinolines featuring an intramolecular radical-oxidative cyclization of polysubstituted pyrroles, and evaluation of their cytotoxic activity.
    Reyes-Gutiérrez PE; Camacho JR; Ramírez-Apan MT; Osornio YM; Martínez R
    Org Biomol Chem; 2010 Oct; 8(19):4374-82. PubMed ID: 20672155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamellarin alkaloids: Isolation, synthesis, and biological activity.
    Fukuda T; Ishibashi F; Iwao M
    Alkaloids Chem Biol; 2020; 83():1-112. PubMed ID: 32098648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research on substances with antiblastic activity. LIV. Tylophera alkaloids. 1. Synthesis of pyrrolo(1,2-b)isoquinoline-10(5H)-one, of benzo(f)pyrrolo(1,2-b)isoquinoline-12(7H)-one and of dibenzo(f,h)pyrrolo(1,2-b)isoquinoline-14(9H)-one].
    De Martino G; Scalzo M; Massa S; Giuliano R
    Farmaco Sci; 1973 Dec; 28(12):976-86. PubMed ID: 4765759
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyrrolo[2,1-a]isoquinoline and pyrrole alkaloids from Sinomenium acutum.
    Lv HN; Zeng KW; Zhao MB; Jiang Y; Tu PF
    J Asian Nat Prod Res; 2018 Mar; 20(3):195-200. PubMed ID: 28503941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel antitumor agents: marine sponge alkaloids, their synthetic analogs and derivatives.
    Dembitsky VM; Gloriozova TA; Poroikov VV
    Mini Rev Med Chem; 2005 Mar; 5(3):319-36. PubMed ID: 15777266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer properties of lamellarins.
    Bailly C
    Mar Drugs; 2015 Feb; 13(3):1105-23. PubMed ID: 25706633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamellarins, from A to Z: a family of anticancer marine pyrrole alkaloids.
    Bailly C
    Curr Med Chem Anticancer Agents; 2004 Jul; 4(4):363-78. PubMed ID: 15281908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pyrrolo[2,1-a]isoquinoline alkaloids.
    Pässler U; Knölker HJ
    Alkaloids Chem Biol; 2011; 70():79-151. PubMed ID: 22308756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamellarins as inhibitors of P-glycoprotein-mediated multidrug resistance in a human colon cancer cell line.
    Plisson F; Huang XC; Zhang H; Khalil Z; Capon RJ
    Chem Asian J; 2012 Jun; 7(7):1616-23. PubMed ID: 22473938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rigidins: Isolation, Bioactivity, and Total Synthesis-Novel Pyrrolo[2,3-d]Pyrimidine Analogues Using Multicomponent Reactions.
    van der Westhuyzen AE; Frolova LV; Kornienko A; van Otterlo WAL
    Alkaloids Chem Biol; 2018; 79():191-220. PubMed ID: 29455836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbazole Scaffold in Medicinal Chemistry and Natural Products: A Review from 2010-2015.
    Tsutsumi LS; Gündisch D; Sun D
    Curr Top Med Chem; 2016; 16(11):1290-313. PubMed ID: 26369811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
    Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.